Whole-blood Point-of-Care Activated Partial Thromboplastin Time Ratio (APR) is not Accurate Enough to Monitor Heparin Therapy in Patients with Severe Respiratory Failure Secondary... by Daniel Aston DPhil, Martin Besser MD, Ben Goddard BSc, Nicholas Maggs BSc, Hassan Ahmed MD, Florian Falter PhD

Get full text